article thumbnail

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT

based Sutter want to be repaid for the money they spent on health insurance from 2011 through 2020.   Terms of the settlement were not immediately released on Monday, but it’s likely sizable given the scope of the case. The individuals and businesses suing Sacramento, Calif.-based

Insurance 129
article thumbnail

STAT+: Medicare Advantage insurers will score $2 billion gift thanks to limited audits

STAT

Medicare officials made a clear statement four years ago about how best to audit the country’s Medicare Advantage insurers: Failing to take back all overpayments “would be contrary to the public interest.” The amount of taxpayer money that insurers will get to keep because of that decision: $2 billion.

Insurance 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves generic Xarelto

The Checkup by Singlecare

Anticoagulants are some of the most commonly prescribed medications in the United States, and Xarelto is an expensive prescription with an average cost of over $600 for a monthly supply without insurance. The FDA originally approved Xarelto in tablet form in 2011 and later approved it as an oral suspension in 2021.

FDA 99
article thumbnail

STAT+: Akili to lay off 46% of its staff, explore strategic options amid sluggish sales

STAT

Founded in 2011, Akili Interactive made waves in 2020 when it received Food and Drug Administration clearance for EndeavorRx , its treatment for young people with ADHD. And almost exactly a year ago, Pear Therapeutics sold off its assets at bankruptcy auction.

Insurance 116
article thumbnail

Opinion: It’s time to rethink the Medicare annual wellness visit

STAT

In 2011, the Centers for Medicare and Medicaid Services created the annual wellness visit (AWV), a new visit type with no cost to Medicare patients, better reimbursement to primary care practices, and higher assigned credit for clinicians’ work.

Insurance 121
article thumbnail

2021 market access prospects for Germany

pharmaphorum

IQWiG sees far less promise in other RWE sources such as electronic medical records and billing records of insurers. Such deals are not national but can be agreed at the insurer level. Any changes to AMNOG will likely be a worry to industry as there has already been a toughening in AMNOG assessments since 2011.”.

article thumbnail

What states use Ozempic the most?

The Checkup by Singlecare

When prescribed for Type 2 diabetes, Ozempic is typically covered by insurance providers. If the injectable medication is prescribed for weight loss, many insurance providers won’t cover it (or its weight-loss counterpart Wegovy )—which is where SingleCare comes in and why people are filling the medication with our coupons.

Insurance 105